Observational Cohort on Rheumatology Practices and Uses FRESH-PEF60035-en Francis GUILLEMIN Observational Cohort on Rheumatology Practices and Uses CORPUS FRESH-PEF60035-en 60035 FRESH-PEF60035 Francis GUILLEMIN CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE NANCY Epidemiology France Portal (PEF) ABBOTT FRANCE MERCK SANTE PFIZER (FRANCE) null Francis;GUILLEMIN Quality of life health healthcare usage resumption of activity biotherapy treatment side effects switch Rheumatology Inflammatory spondyloarthritis Juvenile idiopathic arthritis General objective: to determine the impact of basic prescribed treatment with or without prescribed biotherapy, focussing on the impact of changes in biotherapy over time. Epidemiological recording of the occurrence of adverse events in the long term. Secondary objective: To investigate the role of biotherapy in patient treatment by determining its position in prescribed treatment order during therapeutic sequences. null France Individuals Patients population Male Female Young Adult (19 to 24 years) Adult (25 to 44 years) Middle Aged (45 to 64 years) Aged (65 to 79 years) Aged, 80 and over (80 years and more) All patients that have never received biotherapy and are monitored in one of the participating centres: - patients with active rheumatoid arthritis (with or without prescription), DAS28 score greater than 3.2 regardless of disease onset age, with hand and feet x-rays in the last 3 months - active idiopathic juvenile arthritis (JIA) (with or without prescription), following methrexate intolerance or failure, x-ray in the last 3 months - active (with or without prescription) spondyloarthritis (SPA) (ankylosing or psoriatic arthritis) regardless of disease onset age, pelvic and spinal x-ray in the last 3 months, or of hands and feet according to peripheral or axial form Clinical data Quality of life/health perception Other Through organizations (health services or institutions schools businesses etc.) [500-1000[ individuals Self-administered questionnaire Interview with the participant (including clinical) Observational Study Observational Study Cohort study 640 (407 PAR, 192 SPA, 41 AJI) Unknown Metadata-only access Access on specific project only